Zoltan Szallasi
Molecular Biology · 2006–2023
A researcher in the Science corpus: 15 papers; trusts 4 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 153 citations into it; #9,045 of 17,773 by trust here, #4,951 by citations
Whom Zoltan Szallasi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Zoltan Szallasi overall
Papers from Zoltan Szallasi's perspective
Ordered by how strongly the researchers Zoltan Szallasi trusts endorse each paper. Same corpus, a different order for every researcher.
- Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning (Nature Medicine)
- NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins (Nucleic Acids Res.)
- Evaluation of gene expression measurements from commercial microarray platforms. (Nucleic Acids Research)
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome (Clinical Cancer Research)
- Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. (Journal of Clinical Oncology)
- A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (New England Journal of Medicine)
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer. (Journal of Oncology Practice)
- affy - analysis of Affymetrix GeneChip data at the probe level (Bioinform.)
- The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements (Nature Biotechnology)
- Reliability and reproducibility issues in DNA microarray measurements. (Trends in Genetics)
Their papers
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolution (2015) — 630 citations
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution (2014) — 1,056 citations
- Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer (2016) — 852 citations
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients (2010) — 2,609 citations
- Reliability and reproducibility issues in DNA microarray measurements. (2006) — 626 citations
- Lung adenocarcinoma promotion by air pollutants (2023) — 655 citations
- Neoantigen directed immune escape in lung cancer evolution (2019) — 783 citations
- Tracking the Evolution of Non‐Small‐Cell Lung Cancer (2017) — 2,016 citations
- Phylogenetic ctDNA analysis depicts early stage lung cancer evolution (2017) — 1,635 citations
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing (2012) — 7,381 citations
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. (2012) — 779 citations
- Jetset: selecting the optimal microarray probe set to represent a gene (2011) — 325 citations
- Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. (2010) — 947 citations
- System Modeling in Cellular Biology: From Concepts to Nuts and Bolts (2006) — 296 citations
- A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers (2006) — 1,175 citations